Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Johannesburg
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Adcock Ingram Holdings Ltd

+ Add to Watchlist

AIP:SJ

5,350.00 ZAr 49.00 0.92%

As of 04:44:05 ET on 05/04/2015.

Snapshot for Adcock Ingram Holdings Ltd (AIP)

Open: 5,450.00 Day's Range: 5,307.00 - 5,450.00 Volume: 77,372
Previous Close: 5,301.00 52wk Range: 4,046.00 - 6,306.00 1-Yr Rtn: -10.74%

Stock Chart for AIP

No chart data available.
  • AIP:SJ 5,400.00
  • 1D
  • 1M
  • 1Y
5,301.00
Interactive AIP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AIP

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 24.7595
Relative P/E vs. JALSH -
Earnings Per Share (ZAR) (ttm) -
Est. EPS (ZAR) (06/2015) 2.1410
Est. PEG Ratio -
Market Cap (M ZAR) 9,316.05
Shares Outstanding (M) 175.74
30 Day Average Volume 578,725
Price/Book (mrq) 3.1091
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (ZAr) -
Dividend Ex-Date 01/07/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AIP

  • Revenue
  • Net Income (M/ZAR)
  • Profit Margin (%)

Company Profile & Key Executives for AIP

Adcock Ingram Holdings Limited is a pharmaceutical company. The Company offers a range of generics and prescription medicines across various therapeutic classes.

Kevin B WakefordChief Executive OfficerAndrew Gideon Hall "Andy"Deputy CEO/Finance Director
Kofi AmegashieManaging Dir:Rest of AfricaAshley PearceManaging Dir:Prescription
More Company Profile & Key Executives for AIP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil